Mehran Salek, MD
Obstetrics & Gynecology · Henderson, NVNPI 1558833830
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,858 of the $12,665 with a category attached, or 93.6%. Novartis accounts for 93.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $6,905 and has fallen 98.0% since, to $139 in 2025. Among obstetrics & gynecology clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $226.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$12K
- Inari Medical, Inc.$450
- Organon$70
- AbbVie$51
- BD$51
- Astellas Pharma US Inc$38
- plus $147 from 7 others
What the payments were for
- Consulting fees$11,85894%
- Food & beverage$8076%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 34 | $11,858 |
| Inari Medical, Inc. | 6 | $450 |
| Organon | 3 | $70 |
| AbbVie | 2 | $51 |
| BD | 2 | $51 |
| Astellas Pharma US Inc | 1 | $38 |
| Exact Sciences | 2 | $34 |
| Optumhealth Care Solutions, LLC | 1 | $31 |
| Intra-sana Laboratories | 1 | $20 |
| Indivior Inc. | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GILENYA$9,033
- MAYZENT$2,050
- FLOWTRIEVER CATHETER, S$358
- CT THROMBECTOMY SYSTEM KIT$358
How this compares
$12,665 in reported general payments places this provider in the 90th percentile of 308 obstetrics & gynecology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisinopril | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Henderson
- Guido TorresHenderson$40K
- Silvia Ada Bevilacqua McBrideHenderson$23K
- Douglas TanitaHenderson$21K
- Stepanida FreemanHenderson$18K
- Kevin HsiungHenderson$17K
- Chirag VyasHenderson$16K
- Paula SchwartzHenderson$13K
- Amy Falcone-WhartonHenderson$10K
- Carla TurnerHenderson$9K
- Gerald CasasHenderson$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.